Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (2): 376-380. doi: 10.19723/j.issn.1671-167X.2022.02.028

Previous Articles     Next Articles

Persistent and serious hyperkalemia after surgery of primary aldosteronism: A case report

WANG Wei1,CAI Lin2,GAO Ying1,GUO Xiao-hui1,ZHANG Jun-qing1,()   

  1. 1. Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    2. Department of Urology, Peking University First Hospital, Beijing 100034, China
  • Received:2020-05-15 Online:2022-04-18 Published:2022-04-13
  • Contact: Jun-qing ZHANG E-mail:junqing.zhang@pkufh.com

Abstract:

Hyperkalemia was one of the complications after primary aldosteronism surgery. Hyperkalemia after primary aldosteronism surgery was uncommon in clinical practice, especially persistent and serious hyperkalemia was rare. This complication was not attached great importance in clinical work. A case about persistent and serious hyperkalemia after primary aldosteronism adrenal adenoma surgery was reported and the patient was followed-up for fourteen months in this study. This patient had a laparoscopic adrenalectomy due to primary aldosteronism. Hyperkalemia was detected one month after surgery of this patient, the highest level of plasma potassium was 7.0 mmol/L. The patient felt skin itchy, nausea, palpitation. Plasma aldosterone concentration fell to 2.12 ng/dL post-operation from 35.69 ng/dL pre-operation, zona glomerulosa insufficiency was confirmed by hormonal tests in this patient after surgery. And levels of 24 hours urinary potassium excretion declined. Decrease of aldosterone levels after surgery might be the cause of hyperkalemia. Hyperkalemia lasted for 14 months after surgery and kalemia-lowering drugs were needed. A systemic search with “primary aldosteronism”, “hyperkalemia”, “surgical treatment” was performed in PubMed and Wanfang Database for articles published between January 2009 and December 2019. Literature review indicated that the incidence of hyperkalemia after primary aldosteronism surgery was 6% to 29%. Most of them was mild to moderator hyperkalemia (plasma potassium 5.5 to 6.0 mmol/L) and transient. 19% to 33% in hyperkalemia patients was persistent hyperkalemia. Previous studies in the levels of plasma potassium reached the level as high as 7 mmol/L in our case were rare. Whether hypoaldosteronemia was the cause of hyperkalemia was not consistent in the published studies. Risk factors of hyperkalemia after primary aldosteronism surgery included kidney dysfunction, old age, long duration of hypertention. This paper aimed to improve doctors’ aweareness of hyperkalemia complication after primary aldosteronism surgery. Plasma potassium should be monitored closely after primary aldosteronism surgery, especially in the patients with risk factors. Some patients could have persistent and serious hyperkalemia, and need medicine treatment.

Key words: Primary aldosteronism, Surgery, Hyperkalemia

CLC Number: 

  • R589.4

Figure 1

Levels of plasma potassium, eGFR, PAC pre-operation (pre-op) and post-operation (post-op) PAC, plasma aldosterone concentration; eGFR, estimated glomerular filtration rate."

Table 1

Adrenal hormones, kidney function and electrolyte levels pre- and post-operation"

Items Pre-op 1 month
post-op
3 months
post-op
7 months
post-op
9 months
post-op
14 months
post-op
Normal range
ACTH/(ng/L) 9.33 - 39.53 33.23 - - 7.2-63.3
Serum cortisol/(μg/dL) 10.06 - 20.82 14.95 - - 6.2-19.4
Renin activity/[ng/(mL·h)] 1.32 - - - - - 0.13-2.5
Renin concentration/(mU/L) - - 9.7 24.8 8.6 21.2 4.4-46.1
Plasma aldosterone/(ng/dL) 35.69 - 2.12 8.47 3.96 11.3 3.0-35.3
ARR - - 0.22 0.34 0.46 0.53 <3.7
Creatinine/(μmol/L) 178.23 257.00 206.00 237.00 223.00 226 44-133
eGFR/[mL/(min·1.73 m2)] 33.92 21.79 28.47 24.04 25.87 25.28 >90
Plasma sodium/(mmol/L) 142.08 137.00 138.00 138.00 139.0 137.0 137-147
Plasma potassium/(mmol/L) 3.61 7.00 4.70 6.70 5.10 6.5 3.5-5.3
Plasma chlorine/(mmol/L) 107.6 109.0 106.0 108.0 104.0 108 99-110
CO2/(mmol/L) 27.45 18.80 20.20 17.50 19.50 15 22-30
24 hour urine potassium/(mmol/24 h) - - 23.1 - 52.8 - 25-125
24 hour urine sodium/(mmol/24 h) - - 304.5 - 283.8 - 130-260

Table 2

Summary of literatures about hyperkalemia after surgery in primary aldosteronism patients"

[1] Huang WT, Chau T, Wu ST, et al. Prolonged hyperkalemia following unilateral adrenalectomy for primary hyperaldosteronism[J]. Clin Nephrol, 2010, 73(5):392-397.
pmid: 20420801
[2] Fischer E, Hanslik G, Pallauf A, et al. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy[J]. J Clin Endocrinol Metab, 2012, 97(11):3965-3973.
doi: 10.1210/jc.2012-2234 pmid: 22893716
[3] Chiang WF, Cheng CJ, Wu ST, et al. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma[J]. Clin Chim Acta, 2013, 424(9):114-118.
doi: 10.1016/j.cca.2013.05.017
[4] Hibi Y, Hayakawa N, Hasegawa M, et al. Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyper-parathyroidism: Report of a case[J]. Surg Today, 2015, 45(2):241-246.
doi: 10.1007/s00595-013-0813-0
[5] Tahir A, McLaughlin K, Kline G. Severe hyperkalemia following adrenalectomy for aldosteronoma: Prediction, pathogenesis and approach to clinical management: A case series[J]. BMC Endocr Disord, 2016, 16(1):43.
doi: 10.1186/s12902-016-0121-y pmid: 27460219
[6] Park KS, Kim JH, Yang YS, et al. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism[J]. Endocr J, 2017, 64(6):623-632.
doi: 10.1507/endocrj.EJ16-0530
[7] Wada N, Shibayama Y, Umakoshi H, et al. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism[J]. J Hum Hypertens, 2017, 31(10):627-632.
doi: 10.1038/jhh.2017.38 pmid: 28540931
[8] Takeda M, Yamamoto K, Akasaka H, et al. Clinical characteristics and postoperative outcomes of primary aldosteronism in the elderly[J]. J Clin Endocrinol Metab, 2018, 103(10):3620-3629.
doi: 10.1210/jc.2018-00059 pmid: 30099522
[9] 丁韶丽, 阎文军, 赫曼, 等. 原发性醛固酮增多症患者肾上腺切除术中并发严重高钾血症1例[J]. 中华麻醉学杂志, 2018, 38(4):509-510.
[10] Shariq OA, Bancos I, Cronin PA, et al. Contralateral suppression of aldosterone at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism[J]. Surgery, 2018, 163(1):183-190.
doi: 10.1016/j.surg.2017.07.034
[11] Taniguchi R, Koshiyama H, Yamauchi M, et al. A case of aldosterone-producing adenoma with severe postoperative hyperkalemia[J]. Tohoku J Exp Med, 1998, 186(3):215-223.
pmid: 10348217
[1] YUAN Chang-wei,WANG Ying-jin,ZHANG Shu-jie,SHEN Sheng-li,DUAN Hong-zhou. Clinical outcomes following microsurgery and endovascular embolization in the management of spinal dural arteriovenous fistula: A meta-analysis study [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 304-314.
[2] WANG Xin-guang,GENG Xiao,LI Yang,WU Tian-chen,LI Zi-jian,TIAN Hua. Comparison of alignment and operative time between portable accelerometer-based navigation device and computer assisted surgery in total knee arthroplasty [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 728-733.
[3] YUE Lei,WANG Yue-tian,BAI Chun-bi,CHEN Hao,FU Hao-yong,YU Zheng-rong,LI Chun-de,SUN Hao-lin. Analysis of surgical strategy of percutaneous endoscopic lumbar discectomy in young and middle-aged double-segment patients with lumbar disc herniation [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 734-739.
[4] LIN Guo-zhong, MA Chang-cheng, WANG Zhen-yu, XIE Jing-cheng, LIU Bin, CHEN Xiao-dong. Minimally invasive treatment of cervical1-2 epidural neurilemmoma [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 586-589.
[5] LI Xin-fei, PENG Yi-ji, YU Xiao-teng, XIONG Sheng-wei, CHENG Si-da, DING Guang-pu, YANG Kun-lin, TANG Qi, MI Yue, WU Jing-yun, ZHANG Peng, XIE Jia-xin, HAO Han, WANG He, QIU Jian-xing, YANG Jian, LI Xue-song, ZHOU Li-qun. Three dimensional nephrometry system for partial nephrectomy: Our initial exploration [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 613-622.
[6] Zhi-feng XU,Yun-peng LING,Zhong-qi CUI,hong ZHAO,Yi-chen GONG,Yuan-hao FU,Hang YANG,Feng WAN. Feasibility and safety of minimally invasive cardiac coronary artery bypass grafting surgery for patients with multivessel coronary artery disease: Early outcome and short-mid-term follow up results [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 863-869.
[7] Bei-yu XU,Long-tao QI,Yu WANG,Chun-de LI,Hao-lin SUN,Shi-jun WANG,Zheng-rong YU,Yao ZHAO,Long-long LIU. Clinical efficacy of short-term halo-pelvic traction combined with surgery in the treatment of severe spinal deformities [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 875-880.
[8] Jun-hui ZHANG,Yi-hang JIANG,Yu-guang JIANG,Ji-qing ZHANG,Ning KANG. Clinical outcomes of simultaneous bilateral endoscopic surgery for bilateral upper urinary tract calculi [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 672-677.
[9] Ning KANG,Yi-hang JIANG,Yu-guang JIANG,Li-yang WU,Ji-qing ZHANG,Yi-nong NIU,Jun-hui ZHANG. Endoscopic combined ultrasound-guided access vs. ultrasound-guided access in endoscopic combined intrarenal surgery [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 692-696.
[10] Guo-zhong LIN,Zhen-yu WANG,Jing-cheng XIE,Bin LIU,Chang-cheng MA,Xiao-dong CHEN. Clinical study of 21 cases of sacral cysts containing fila terminale [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 582-585.
[11] Chang-cheng MA,Zhen-yu WANG,Guo-zhong LIN. Diagnosis and treatment of primary intraspinal abscess [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 275-280.
[12] Lei HOU,Guo-hua YE,Xiao-jing LIU,Zi-li LI. Evaluation of mandibular stability and condylar volume after orthognathic surgery in patients with severe temporomandibular joint osteoarthrosis [J]. Journal of Peking University(Health Sciences), 2020, 52(1): 113-118.
[13] Fei WANG,Yang-yang ZHAO,Ming GUAN,Jing WANG,Xiang-liang XU,Yu LIU,Xin-li ZHAI. Application of intravenous sedation in 2 582 cases of oral and maxillofacial surgery [J]. Journal of Peking University(Health Sciences), 2020, 52(1): 181-186.
[14] Xian-tao SUN,Wei HE,Xiao-jing LIU,Zi-li LI,Xing WANG. Feasibility of Delaire cephalometric analysis to predict the ideal sagittal position of the maxilla and chin for surgery-first patients in orthognathic surgery [J]. Journal of Peking University(Health Sciences), 2020, 52(1): 90-96.
[15] Jian-hua ZHU,Jing WANG,Xiao-jing LIU,Chuan-bin GUO. Accuracy analysis of robotic assistant needle placement for trigeminal gasserian ganglion [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 973-976.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Xin-yu WANG,Zhe CUI,Qing-yuan HE,Xiang-ning DENG,Ge GUO,Xin-heng FENG,Jie-li FENG. Assessment of heart’s changes of elite Chinese male weightlifter by speckle tracking echocardiography[J]. Journal of Peking University (Health Sciences), 2021, 53(5): 832 -837 .
[2] . [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 1 -6 .
[3] . [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1017 -1019 .
[4] LOU Xue,LIAO Li,LI Xing-jun,WANG Nan,LIU Shuang,CUI Ruo-mei,XU Jian. Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis[J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1020 -1025 .
[5] ZHONG Hua,XU Li-ling,BAI Ming-xin,SU Yin. Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis[J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1026 -1031 .
[6] . [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 633 -634 .
[7] . [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 828 -831 .
[8] . [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 635 -639 .
[9] YU Yan-fei,HE Shi-ming,WU Yu-cai,XIONG Sheng-wei,SHEN Qi,LI Yan-yan,YANG Feng,HE Qun,LI Xue-song. Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma[J]. Journal of Peking University (Health Sciences), 2021, 53(4): 640 -646 .
[10] WANG Li-xin , XU Xiao, NI Yao-feng, SUN Hai-tao, YU Ri-yue, WEI Shi-cheng. In vivo study of liposome-modified polyetheretherketone implant on bacteriostasis and osseointegration[J]. Journal of Peking University (Health Sciences), 2021, 53(4): 758 -763 .